{"entity":{"type":"insider","cik":"0001407235","url":"/insider/0001407235","json_url":"/insider/0001407235.json","name":"Garner William J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":13,"first":"2009-01-21","last":"2015-07-17","span_basis":"filed_date"},"name_variants":[{"name":"Garner William J","source":"filing","n_filings":13,"first_seen":"2009-01-21","last_seen":"2015-07-17"}],"transactions":[{"id":8856855,"accession":"0001013762-15-000734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-15-000734","line_url":"/filing/0001013762-15-000734#line-1","is_derivative":false,"issuer_cik":"0001407235","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001407235","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16666.0,"shares_display":"16,666","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":9999.6,"total_display":"9,999.60","total_whole":"10,000","shares_owned_after":2415207.0,"shares_owned_after_display":"2,415,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-16","filed_date":"2015-07-17","scope":"insider"},{"id":7043653,"accession":"0001013762-14-000263","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013762-14-000263","line_url":"/filing/0001013762-14-000263","is_derivative":false,"issuer_cik":"0001407235","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001407235","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":104000.0,"total_display":"104,000.00","total_whole":"104,000","shares_owned_after":65000.0,"shares_owned_after_display":"65,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2014-03-20","scope":"insider","n_lines":5},{"id":4769405,"accession":"0001013762-13-001248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-13-001248","line_url":"/filing/0001013762-13-001248#line-1","is_derivative":false,"issuer_cik":"0001407235","issuer_name":"DelMar Pharmaceuticals, Inc.","issuer_ticker":"DMPI","issuer_name_source":null,"issuer_url":"/issuer/0001407235","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-20","filed_date":"2013-09-23","scope":"insider"},{"id":5977359,"accession":"0001013762-09-000433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000433","line_url":"/filing/0001013762-09-000433#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":90.0,"total_display":"90.00","total_whole":"90","shares_owned_after":18586340.0,"shares_owned_after_display":"18,586,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-13","filed_date":"2009-03-16","scope":"insider"},{"id":5706626,"accession":"0001013762-09-000456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000456","line_url":"/filing/0001013762-09-000456#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":90.0,"total_display":"90.00","total_whole":"90","shares_owned_after":18587340.0,"shares_owned_after_display":"18,587,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-13","filed_date":"2009-03-18","scope":"insider"},{"id":5678155,"accession":"0001013762-09-000421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000421","line_url":"/filing/0001013762-09-000421#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":90.0,"total_display":"90.00","total_whole":"90","shares_owned_after":18585340.0,"shares_owned_after_display":"18,585,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-11","filed_date":"2009-03-13","scope":"insider"},{"id":5660056,"accession":"0001013762-09-000381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000381","line_url":"/filing/0001013762-09-000381#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.08,"price_display":"0.08","price_state":"stated","total_value":400.0,"total_display":"400.00","total_whole":"400","shares_owned_after":18584340.0,"shares_owned_after_display":"18,584,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-05","filed_date":"2009-03-06","scope":"insider"},{"id":5748315,"accession":"0001013762-09-000322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000322","line_url":"/filing/0001013762-09-000322#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":100.0,"total_display":"100.00","total_whole":"100","shares_owned_after":18579340.0,"shares_owned_after_display":"18,579,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-25","filed_date":"2009-02-26","scope":"insider"},{"id":5632343,"accession":"0001013762-09-000171","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013762-09-000171","line_url":"/filing/0001013762-09-000171","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17800.0,"shares_display":"17,800","price_per_share":0.1343820224719101,"price_display":"0.13","price_state":"stated","total_value":2392.0,"total_display":"2,392.00","total_whole":"2,392","shares_owned_after":18578340.0,"shares_owned_after_display":"18,578,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-30","filed_date":"2009-02-03","scope":"insider","n_lines":2},{"id":5632341,"accession":"0001013762-09-000171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000171","line_url":"/filing/0001013762-09-000171#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":2400.0,"total_display":"2,400.00","total_whole":"2,400","shares_owned_after":18560540.0,"shares_owned_after_display":"18,560,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-29","filed_date":"2009-02-03","scope":"insider"},{"id":5584258,"accession":"0001013762-09-000140","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013762-09-000140","line_url":"/filing/0001013762-09-000140","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":1200.0,"total_display":"1,200.00","total_whole":"1,200","shares_owned_after":18544540.0,"shares_owned_after_display":"18,544,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-27","filed_date":"2009-01-29","scope":"insider","n_lines":2},{"id":5584256,"accession":"0001013762-09-000140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000140","line_url":"/filing/0001013762-09-000140#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.17,"price_display":"0.17","price_state":"stated","total_value":850.0,"total_display":"850.00","total_whole":"850","shares_owned_after":18534540.0,"shares_owned_after_display":"18,534,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-26","filed_date":"2009-01-29","scope":"insider"},{"id":9215602,"accession":"0001013762-09-000139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000139","line_url":"/filing/0001013762-09-000139","is_derivative":false,"issuer_cik":"0001407235","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0001407235","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48000.0,"shares_display":"48,000","price_per_share":0.09895833333333333,"price_display":"0.10","price_state":"stated","total_value":4750.0,"total_display":"4,750.00","total_whole":"4,750","shares_owned_after":18486540.0,"shares_owned_after_display":"18,486,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-21","filed_date":"2009-01-29","scope":"insider","n_lines":2},{"id":5604349,"accession":"0001013762-09-000099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000099","line_url":"/filing/0001013762-09-000099#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48000.0,"shares_display":"48,000","price_per_share":0.045,"price_display":"0.04","price_state":"stated","total_value":2160.0,"total_display":"2,160.00","total_whole":"2,160","shares_owned_after":18529540.0,"shares_owned_after_display":"18,529,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-21","filed_date":"2009-01-22","scope":"insider"},{"id":5686710,"accession":"0001013762-09-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013762-09-000073","line_url":"/filing/0001013762-09-000073#line-1","is_derivative":false,"issuer_cik":"0000932352","issuer_name":"Urigen Pharmaceuticals, Inc.","issuer_ticker":"UGRP.OB","issuer_name_source":null,"issuer_url":"/issuer/0000932352","owner_cik":"0001407235","owner_name":"Garner William J","owner_display_name":"Garner William J","owner_url":"/insider/0001407235","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, $.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.045,"price_display":"0.04","price_state":"stated","total_value":225.0,"total_display":"225.00","total_whole":"225","shares_owned_after":18481540.0,"shares_owned_after_display":"18,481,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-20","filed_date":"2009-01-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":17,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001498382","name":"DelMar Pharmaceuticals, Inc.","url":"/issuer/0001498382","role":"Director","n_filings":3,"first_seen":"2013-09-23","last_seen":"2015-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000932352","name":"Urigen Pharmaceuticals, Inc.","url":"/issuer/0000932352","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":10,"first_seen":"2009-01-21","last_seen":"2009-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001407235","retrieved_at":"2026-08-22T22:52:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}